INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAC2. A total of 11 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 98,354,000 | $95,235,195 | 1.97% |
| Graham Capital Management, L.P. | 5,747,000 | $5,883,484 | 0.18% |
| COWEN AND COMPANY, LLC | 1,000,000 | $991,250 | 0.10% |
| LAZARD ASSET MANAGEMENT LLC | 4,500,000 | $4,602 | 0.01% |
| Man Group plc | 825,000 | $843,563 | 0.00% |
| Bank of New York Mellon Corp | 300,000 | $291,549 | 0.00% |
| JPMORGAN CHASE & CO | 175,000 | $175 | 0.00% |
| JANE STREET GROUP, LLC | 60,000 | $57,525 | 0.00% |
| AMERICAN CENTURY COMPANIES INC | 97,000 | $99,207 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |